We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
Staged intact canal wall tympanoplasty for treatment of middle ear cholesteatoma.
Nihon Jibiinkoka Gakkai Kaiho 1998 Februrary
Results of surgery for middle ear cholesteatoma were investigated in 202 ears of 197 patients who had undergone surgery by the staged intact canal wall technique. Surgical procedures used in the second stage for prevention of a retraction pocket were classified into three types: Type S1, no scutumplasty; Type S2, scutumplasty; Type S3, scutumplasty plus mastoid obliteration. Recurrent cholesteatoma was found in 9 ears (4%) and retraction pocket in 47 ears (23%). They occurred between 2 and 120 months (average: 26 months) after the second stage, most frequently at 1 to 3 years. The incidence was higher after Type S3 surgery than after the other types, probably because the middle ear was severely involved in patients who were indicated Type S3 surgery. For prevention of a retraction pocket, bone putty and cartilage were proved to be appropriate materials for scutumplasty, and hydroxyapatite for mastoid obliteration. As the retraction pocket tended to recur in patients with the pocket at the second stage, these patients needed obliteration of the mastoid cavity to prevent a retraction pocket. Postoperative hearing was evaluated according to the criteria proposed by the Japan Society of Clinical Otology. Of 145 ears of the 142 patients who were followed for more than 1 year, 118 ears (81%) the surgery was judged successful. The success rate in hearing was in good accordance with the condition of the tympanic membrane.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app